Ermolieff J, Boudier C, Laine A, Meyer B, Bieth J G
Laboratoire d'Enzymologie, INSERM Unité 392, Université Louis Pasteur de Strasbourg, Illkirch, France.
J Biol Chem. 1994 Nov 25;269(47):29502-8.
Cathepsin G, a cationic serine proteinase present in neutrophils and monocytes, is able to cleave biologically important proteins and may thus participate in tissue destruction during inflammation. Its activity is physiologically controlled by the fast-acting serpins, alpha 1-anti-chymotrypsin (ka = 5 x 10(7) M-1 S-1) and alpha 1-proteinase inhibitor (ka = 2.7 x 10(5) M-1 S-1). We have shown that cathepsin G forms a tightly bound 1:1 complex with a 5-kDa heparin fragment (Kd = 1.9 x 10-8 M). The partial enzymatic activity retained by this complex is inhibited extremely slowly by the above 68- and 53-kDa serpins. The activity of the complex is also virtually resistant to inhibition by eglin c, and 8-kDa non-serpin inhibitor. A detailed kinetic investigation showed that the inhibition of heparin-bound cathepsin G by the three proteins proceeded via a two-step mechanism. [formula: see text] The three inhibitors have widely different Ki* values (0.18-13 microM) (Ki* = k-1/k1). Their isomerization constants k2 are, however, all in the same range and their extremely low values (0.7-3 ms-1) account for the very low rate of cathepsin G inhibition. The second-order inhibition rate constants k2/Ki* were 4300, 700, and 52 M-1 S-1 for alpha 1-antichymotrypsin, alpha 1-antitrypsin, and eglin c, respectively, indicating that, if heparin is present in vivo, the two former physiological inhibitors will be unable to prevent cathepsin G-mediated proteolysis. Neutrophil elastase binds the 5-kDa heparin fragment with an affinity identical to that of cathepsin G. alpha 1-Proteinase inhibitor reacts, however, much faster with heparin-elastase (ka = 1.8 x 10(6) M-1 S-1) than with heparin-cathepsin G (k2/Ki* = 700 M-1 S-1).
组织蛋白酶G是一种存在于中性粒细胞和单核细胞中的阳离子丝氨酸蛋白酶,能够裂解具有生物学重要性的蛋白质,因此可能参与炎症过程中的组织破坏。其活性在生理上受快速作用的丝氨酸蛋白酶抑制剂控制,即α1 - 抗糜蛋白酶(ka = 5×10⁷ M⁻¹ s⁻¹)和α1 - 蛋白酶抑制剂(ka = 2.7×10⁵ M⁻¹ s⁻¹)。我们已经表明,组织蛋白酶G与一个5 kDa的肝素片段形成紧密结合的1:1复合物(Kd = 1.9×10⁻⁸ M)。该复合物保留的部分酶活性被上述68 kDa和53 kDa的丝氨酸蛋白酶抑制剂极其缓慢地抑制。该复合物的活性实际上也对依格林c和8 kDa非丝氨酸蛋白酶抑制剂的抑制具有抗性。详细的动力学研究表明,三种蛋白质对肝素结合的组织蛋白酶G的抑制通过两步机制进行。[公式:见正文]这三种抑制剂具有广泛不同的Ki值(0.18 - 13 μM)(Ki = k⁻¹/k1)。然而,它们的异构化常数k2都在相同范围内,并且其极低的值(0.7 - 3 ms⁻¹)解释了组织蛋白酶G抑制速率非常低的原因。对于α1 - 抗糜蛋白酶、α1 - 抗胰蛋白酶和依格林c,二级抑制速率常数k2/Ki分别为4300、700和52 M⁻¹ s⁻¹,这表明,如果体内存在肝素,前两种生理抑制剂将无法阻止组织蛋白酶G介导的蛋白水解。中性粒细胞弹性蛋白酶与5 kDa肝素片段的结合亲和力与组织蛋白酶G相同。然而,α1 - 蛋白酶抑制剂与肝素 - 弹性蛋白酶(ka = 1.8×10⁶ M⁻¹ s⁻¹)的反应比与肝素 - 组织蛋白酶G(k2/Ki = 700 M⁻¹ s⁻¹)快得多。